TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of maintained soft tissue approximation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in participant self-efficacy for finding community resources
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction of participants
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recruitment and participation of participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost of the trial
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Biomechanical properties of plantar fascia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Viscoelastic properties of plantar fascia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in serum klotho levels at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum klotho levels at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended Phase II Dose (RP2D)
Endpoint domain: Resource use
Primary endpoint: Proportion of children 10-14 months with impaired fine and gross motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children 20-24 months with impaired cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CD +8 TIL frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in List Sorting Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Digits Span Forwards and Backwards
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Halimetry Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality predictor
Endpoint domain: Mortality/survival
Primary endpoint: Change in tooth lengths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the alveolar bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Value of Multiple Traffic Light Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and severity of any adverse medication-related symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: blood DNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Symptomatic Influenza Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Severity of Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD signal levels during resting state fMRI sequence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BOLD signal levels during fMRI memory encoding task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BOLD signal levels during fMRI n-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: International Physical Activity Questionnaire (IPAQ) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD diagnosis and severity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EORTC Scale for Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to event endpoints
Endpoint domain: Mortality/survival
Primary endpoint: TEAEs and Serious TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetic (PK) in plasma digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK in plasma rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK in plasma metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK in plasma povorcitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of HF follow up program to patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of HF follow up program to patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of scheduled visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dental Plaque Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of elevated blood pressure measurements that are repeated during the same clinic visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients who newly meet clinical criteria for hypertension who are clinically recognized
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rewarming time difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Early diagnosis of PsA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the Chinese version of Perceived Stress Scale (PSS score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of depression Anxiety Stress Scale (DASS score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of heart rate variability (HRV) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: decision-to-groin time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of DLTs (Dose Limiting Toxicities) within 90 days post injection
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of DLTs (Dose Limiting Toxicities) from Day 91 to Day 365
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Intensity and interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower back pain related Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life with chronic low back pain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Reduction in Cylindrical Power of the Eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baxter Nausea Scale- BARF Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Eastern Ontario Children's Hospital Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Perioperative Anxiety Scale (MCPSPS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's Emotional Indicator Scale (CBRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinically significant bleeds per patient-week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change in Hemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Left ventricular dp/dt (maximal and minimal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular end-systolic pressure (maximal and minimal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rScO2 measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Support needs of relatives of palliative patients
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Proportion of people happy to be contacted
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe adverse device events (SADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Comfort level of wearing assistive shoe
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 30-day all cause death
Endpoint domain: Mortality/survival
Primary endpoint: Days alive and out of hospital
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: MACCE at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total new lesion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Postoperative visual acuity with or without spectacle correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vision-related quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent of participants with treatment related Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: semi-quantitative analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Targeted lesion failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ratings of child participant's pre physiotherapy anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ratings pain of child participant's post physiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratings of child participant's movement during physiotherapy sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: National Annie Colonoscopy Survey Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of progression to active Multiple Myeloma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Oocyte pick-up at retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change from baseline Brunel Lifestyle Physical Activity Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline Moderate-Vigorous Physical Activity Using Actigraph
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pectoralis Minor Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Scapula Upward Rotation Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of possible contaminants with Covid-19
Endpoint domain: Adverse events/effects
Primary endpoint: Odds ratios of identified modifier genes/variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Telitacicept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax of Telitacicept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ctrough of Telitacicept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cav of Telitacicept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of Telitacicept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2z of Telitacicept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eosinophilia recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of microRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Weight of Pregnant Woman
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Height of Pregnant Woman
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass Index of Pregnant Woman
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: infusion reactions
Endpoint domain: Adverse events/effects
Primary endpoint: anti-HLA antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Primary shunt patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of ularitide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant normalized weight at 6 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence in the course
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Lower Extremity Power Horizontal Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Power Vertical Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perineal Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell composition of immune organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Epigenetic status of cells of immune organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CXCL5 level in SLE patients compared to healthy controls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CXCL5 level in association with disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Postoperative Pain Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biologically verified continuously smoking abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerosol particle concentrations at 1 foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerosol particle concentrations at 3 feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total pelvic floor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total pelvic floor symptoms related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: pre-basal activity of the pelvic floor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digital goniometer measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MetaMotionRLs measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal oxygen uptake (VO2 max.)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With HAE Attacks Occurrence During Study Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Interval Between HAE Attacks During Study Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Each HAE Attacks During Study Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in modified Ashworth scale (MAS) for spastic plantar flexor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement of Passive ankle dorsiflexion range of motion (PADFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in time required to walk 10 meters (10 MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of improvement or worsening at least one point change in ordinal scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Contrast sensitivity testing post imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity and Risk of AE
Endpoint domain: Adverse events/effects
Primary endpoint: Severity and Risk of SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Delayed visual recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Masseter muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Severity of Frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Mini Mental State Examination (MMSE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Montreal Cognitive Assessment (MoCA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Clinical Dementia Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grade 3-5 chemotherapy toxicity risk
Endpoint domain: Adverse events/effects
Primary endpoint: reduction in Eczema Area and Severity Index (EASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ASOF scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sQOD-NS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline of Transcranial magnetic stimulation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of subjects requiring oxygen by Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Cone Contrast Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Response Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of clinically significant Prostate cancer (csPCa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: All-cause Health Care Resource Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: COPD-related Health Care Resource Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the receiver operator characteristics curve for prediction of fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in time spent in tighter glucose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number and types of falls risks identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken and level of completion of the programme
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Barriers and facilitators to completing the programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wall Shear Stress level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ulcerated oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyposalivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who decide to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of patients who remain in the study to completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of durably isolated pulmonary veins (PVs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of patients developing PMPS
Endpoint domain: Adverse events/effects
Primary endpoint: Glucose time-in-range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of pCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of patients achieving ADCT score less than 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of influenza vaccination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of pertussis vaccination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Children's Perioperative Multidimensional Anxiety Scale (CPMAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amino Acid concentration in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of peak torque of Isokinetic muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of Fatigue index of isokinetic muscle strength
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline confidence in cooking
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Media Parenting Behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Level of post-operative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes